Ci bi mu melGis bi ci topp
AI in Lung Cancer Screening CT
Liggéeyukaay yi
GUIDE usine
AI in mammography uses image-analysis models to flag suspicious areas on breast X-rays and estimate cancer risk, most often as a second reader or triage tool alongside radiologists rather than a replacement for them.
Déglul tegtal biiIA-nettali · ~3 min
It matters because screening programs face radiologist shortages, and large trials suggest AI support can find more cancers while reducing reading workload. Questions about false positives, interval cancers and dense breast tissue still shape how it is used.
Screening mammography looks for early breast cancer in women without symptoms. Radiologists compare views of each breast, look for masses, calcifications, asymmetries and architectural distortion, and decide whether to recall the woman for more tests. In much of Europe, two radiologists read each exam independently. In the United States, one radiologist usually reads it. Computer-aided detection is not new. Traditional CAD was approved in the late 1990s and became widely used in the US, but large studies found it did not clearly improve accuracy and added false marks. Modern deep learning systems, such as Lunit INSIGHT MMG, iCAD ProFound AI and ScreenPoint Transpara, learn from very large sets of images with known outcomes and give each exam a suspicion score as well as region markers. The strongest evidence comes from prospective trials in real screening programs. Sweden's MASAI randomized trial, first reported in The Lancet Oncology in 2023, used AI to triage exams: low-risk exams got one reader and high-risk exams got two. It found cancer detection was at least as good as standard double reading, with a large reduction in radiologist reading workload and a similar false-positive rate. Later MASAI results and studies elsewhere, including a large German real-world study, reported higher detection rates with AI support. Important limits remain. Finding more cancers does not automatically mean saving more lives, because some detected cancers are slow-growing, and a key long-term measure is interval cancers, which appear between screenings. Dense breast tissue appears white on mammograms, the same as many tumors, which can hide cancers from both humans and AI. A common misconception is that AI reads mammograms by itself. In current programs, radiologists make the recall decisions.
In a European double-reading program, exams the AI scores as low risk are read by one radiologist instead of two, while exams it scores as high risk get two readers.
A radiologist sees an AI marker on a small cluster of calcifications she had not flagged, looks again, and recalls the patient for diagnostic imaging.
A screening service uses AI risk scores to sort the day's worklist so the most suspicious exams are read first.
A clinic reviewing its AI results notices that dense breast tissue makes some exams harder for both readers and software, and adds a policy on when to discuss supplemental ultrasound or MRI.
The next important evidence will come from longer follow-up of screening trials, especially whether AI support reduces interval cancers and advanced cancers rather than only raising detection counts. Programs are also studying AI for risk prediction, which could help personalize screening intervals or identify women who may benefit from supplemental imaging. Uptake will depend on regulation, reimbursement, radiologist trust and ongoing monitoring for performance drift when equipment changes. A reasonable expectation is broader use as a second reader and triage tool, with radiologists keeping responsibility for recall and diagnosis.
Bulletin bu amul fayda
Ñatti jaar-jaari IA yuñ firndeel bis bu nekk ci ayu-bis bi, ñu bind leen ci Àngle bu leer. Gratis ba fàww, amul yëgle.
Benn email bis bu nekk ci ayu-bis bi. Benn klik nga dindi abonemaa bi. Dunu musa jaay wala séddoo sa adres.
Nattal sa bopp
Feedback ci saasi ci bépp tontu, ak sertifikaa buñ mëna séddoo ak ID buñ mëna saytu soo jàllee ci njàng mi.
Jàppale njàngum IA te doo fay. AI Understanding mbootaay la buy def te Yàlla tax — amul yëgle, amul paywall, musul am. Defal ab sarax
AI in mammography uses image-analysis models to flag suspicious areas on breast X-rays and estimate cancer risk, most often as a second reader or triage tool alongside radiologists rather than a replacement for them. It matters because screening programs face radiologist shortages, and large trials suggest AI support can find more cancers while reducing reading workload. Questions about false positives, interval cancers and dense breast tissue still shape how it is used.
MASAI dafa jëfandikoo poñ risku IA ngir mëna tànn ni ñuy jàngee, loolu wàññi na liggéey bi ba noppi baña bàyyi gis cancer bi gëna baax ci li ñuy jàng ñaari yoon.
CAD bu yàgg bi dañu ko jëfandikoo bu baax waaye joxeewul njariñ yu leer ci njub, moo tax IA bu bees bi ñuy àtte ci ay test yu jëm kanam.
Tisu bu dëgër bi ak tumër yi dañu weex, suko defee ñu mëna maskeer cancer yi. Loolu dafay jàpp nit ñi ak IA yépp.
Li gëna mëna gis mën na nekk cancer yuy màgg ndànk. Lu gëna néew luñuy am ci diggante cancer yi mooy firnde bu gëna am solo ci njariñ dëgg.
Buntu jënd ak jaay sensitiwite ngir mën mën. Lu gëna am yëg-yëg mooy gëna bari njuumte ak fàttaliku.
Weyal di jàng
Tann nañu yeneen njiit ngir topic bii
Ci bi mu melGis bi ci topp
AI in Lung Cancer Screening CT
Liggéeyukaay yi